Huntingtin Polyglutamine-Dependent Protein Aggregation in Reconstituted Cells

Area of Science:

• Synthetic biology
• Biochemistry
• Cell biology

Background:

• Synthetic biology aims to build artificial cells for medical applications.
• Huntington's disease is characterized by protein aggregates of Huntingtin protein fragments with polyglutamine (Htt-polyQ) sequences.

Discussion:

• Giant unilamellar vesicles (GUVs) encapsulating HeLa cell extract with a cell-free protein synthesis (CFPS) system were used to express Htt-polyQ fragments.
• The system recapitulated polyglutamine-dependent protein aggregate formation, mirroring observations in living cells.
• A simplified GUV system with purified human factors also reconstituted CFPS and showed similar Htt-polyQ aggregation.
• An N-terminal deletion mutant, previously shown not to aggregate in living cells, also failed to aggregate in the reconstituted GUVs, validating the model.

Key Insights:

• Reconstituted human cells using GUVs and CFPS can model disease-specific protein aggregation.
• The GUV system accurately reflects the behavior of disease-related protein mutants.
• This approach provides a powerful in vitro platform for studying neurological disorders.

Outlook:

• These reconstituted GUV systems offer a simplified, controllable model for studying the molecular mechanisms of neurological diseases.
• This technology holds potential for drug screening and therapeutic development for conditions like Huntington's disease.